The burden of cardiovascular disease (CVD) is increasing worldwide. The increase in the
burden is a major concern in developing countries like India. It is well-established that …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are extremely effective at
reducing low-density lipoprotein (LDL) cholesterol and have been demonstrated to reduce …

Redusert venstre ventrikkelfunksjon er en selvstendig og sterkt ugunstig prognostisk faktor.
Vurdering av venstre ventrikkelfunksjon med for eksempel ekkokardiografi anbefales utført …

Hematologic parameters have prognostic importance in cardiovascular disease. However,
the relation between atherosclerosis progression and hematologic parameters is not well …

Objective: To elucidate the bidirectional correlation of sarcopenia with coronary heart
disease (CHD), as well as to investigate the mediating role of cardiometabolic factors and …

Objectives: The purpose of this study was to characterize the determinants of plaque
progression despite achieving very low levels of low-density lipoprotein cholesterol (LDL-C) …

Background Patients with a history of cardiovascular disease are at high risk of developing
secondary major adverse cardiac events (MACE). This study aimed to identify independent …

Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly
adults, but the consequences of lipid exposure during young adulthood are unclear …

Objectives: The aim of this study was to evaluate the impact of olmesartan on progression of
coronary atherosclerosis. Background: Prior intravascular ultrasound (IVUS) trial results …